Found: 25
Select item for more details and to access through your institution.
Editorial: Quantity is important! Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Editorial: The future of managing drug induced liver injury.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 686, doi. 10.1111/apt.18194
- By:
- Publication type:
- Article
Meta‐analysis: High pooled positive predictive value of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition no‐biopsy approach for coeliac disease testing in children.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 672, doi. 10.1111/apt.18177
- By:
- Publication type:
- Article
Editorial: Tracking the course of Wilson's disease: Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Editorial: Decoding the enigma—Navigating complexity in MASLD management. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Quantity is important!
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Review article: Oesophageal disorders in chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 715, doi. 10.1111/apt.18193
- By:
- Publication type:
- Article
Review article: advances in the diagnosis and management of anorectal motility disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 701, doi. 10.1111/apt.18170
- By:
- Publication type:
- Article
Clinical trial: The effectiveness of long‐acting somatostatin analogue for output reduction of high‐output intestinal fistula or small bowel enterostomy. A randomised controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 727, doi. 10.1111/apt.18166
- By:
- Publication type:
- Article
Editorial: Decoding the enigma—Navigating complexity in MASLD management.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 796, doi. 10.1111/apt.18165
- By:
- Publication type:
- Article
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Clinical characteristics and HLA associations of azithromycin‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 787, doi. 10.1111/apt.18160
- By:
- Publication type:
- Article
Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 778, doi. 10.1111/apt.18159
- By:
- Publication type:
- Article
Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 765, doi. 10.1111/apt.18154
- By:
- Publication type:
- Article
Editorial: Tracking the course of Wilson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Other causes of neurocognitive impairment than covert hepatic encephalopathy (CHE) are very frequent, either alone or associated with CHE, in cirrhotic patients with cognitive complaints.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 749, doi. 10.1111/apt.18148
- By:
- Publication type:
- Article
Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 737, doi. 10.1111/apt.18139
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 669, doi. 10.1111/apt.17589
- Publication type:
- Article